Conversely, another study by Hauck et al. (2020) showed that induced cardiac-specific Pkm2 KO promotes cardiomyocyte cell cycle re-entry, improves cardiac function, and reduces scar size after MI [111]. The gene discussed is PKM; the disease is myocardial infarction.